ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

11,969Medicare Part D Prescriptions Filled, Including Refills
$626K Total Retail Price of All Prescriptions
345 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 501 477
LEVOTHYROXINE SODIUM 442 432
FUROSEMIDE 328 266
DONEPEZIL HCL 318 306
AMLODIPINE BESYLATE 295 284
NAMENDA 283 266
METOPROLOL TARTRATE 246 228
HYDROCODONE-ACETAMINOPHEN 241 230 S3
WARFARIN SODIUM 233 225
ATORVASTATIN CALCIUM 208 199
PREDNISONE 203 172
LISINOPRIL 190 157
DIOVAN 170 170
POTASSIUM CHLORIDE 163 140
NOVOLOG 159 144
CARVEDILOL 158 129
QUETIAPINE FUMARATE 156 153
LOVASTATIN 155 152
SIMVASTATIN 155 125
PANTOPRAZOLE SODIUM 150 134
ALBUTEROL SULFATE 138 112
TAMSULOSIN HCL 138 138
GABAPENTIN 128 125
ACETAMINOPHEN-CODEINE 127 95 S3
ZOLPIDEM TARTRATE 122 98
DIGOXIN 120 120
BENAZEPRIL HCL 116 106
IPRATROPIUM BROMIDE 115 95
METFORMIN HCL 108 94
ADVAIR DISKUS 107 95
HYDRALAZINE HCL 106 105
TRIAMTERENE-HCTZ 103 103
SERTRALINE HCL 102 101
LEVETIRACETAM 99 99
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 97
LANTUS 89 79
NAPROXEN 87 75
AMIODARONE HCL 87 85
ATENOLOL 86 74
OXYCODONE HCL 85 80 S2
LOSARTAN POTASSIUM 81 63
CARBIDOPA-LEVODOPA 79 76
GLIPIZIDE 79 79
MIRTAZAPINE 77 76
RISPERIDONE 77 77
LACTULOSE 76 70
SEROQUEL 75 72
ONDANSETRON HCL 75 65
TRIAMTERENE-HYDROCHLOROTHIAZID 74 56
CLOPIDOGREL 73 65
JANTOVEN 71 71
PLAVIX 71 63
HYDROCHLOROTHIAZIDE 70 55
CLOTRIMAZOLE-BETAMETHASONE 69 59
ENOXAPARIN SODIUM 69 40
ALLOPURINOL 67 61
CITALOPRAM HBR 67 64
JANUVIA 64 64
AZITHROMYCIN 62 54
SPIRIVA 56 53
FLUOCINONIDE 55 51
ESCITALOPRAM OXALATE 53 53
CYMBALTA 52 49
GEMFIBROZIL 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.